NL-OMON49023已完成不适用
A Prospective, multicenter, observational study to identify deleterious novel variants of the DPYD gene in patients of non-Western descent: The DPYD-NOW study - Indentifying variants of DPYD in patients of non-Western descent
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Pathologically confirmed malignancy for which treatment with a
- •fluoropyrimidine is considered to be in the patient*s best interest
- •2. Patients need to be self-declared non-Western
- •3. Age * 18 years
- •4. Able and willing to give written informed consent;
- •5. WHO performance status of 0, 1 or 2
- •6. Life expectancy of at least 12 weeks
- •7. Able and willing to undergo blood sampling for study related analysis
- •8. Adequate baseline patient characteristics (complete blood count, hepatic
- •function which involves serum bilirubin, AST, ALT, and renal function)
排除标准
- •1. Prior treatment with fluoropyrimidines
- •2. Patients with known substance abuse, psychotic disorders, and/or other
- •diseases expected to interfere with study or the patient*s safety
研究者
相似试验
招募中
4 期
Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab in the treatment of rheumatoid arthritisrheumatoid arthritisITMCTR2100005277The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
已完成
不适用
Impact of OCT guided imaging in decision making in PCICTRI/2018/10/015872isie Hospital500
招募中
Unknown
Evaluation of the Therapeutic Effects of a Combination Drug Containing Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Coexisting Hypertension and DyslipidemiaKCT0008610Pusan National University Yangsan Hospital550
尚未招募
4 期
An Observational study to evaluate the safety and effectiveness of Rejoint Max® in Indian Patients with Osteoarthritis of KneeCTRI/2020/03/023852Abbott Healthcare Pvt Ltd
招募中
不适用
Study to check safety and effectiveness of cilnidipine, metoprolol succinate and chlorthalidone in Indian hypertensive patients.CTRI/2019/01/017089Aprica Healthcare Pvt Ltd